These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9354430)
1. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Hunt KK; Deng J; Liu TJ; Wilson-Heiner M; Swisher SG; Clayman G; Hung MC Cancer Res; 1997 Nov; 57(21):4722-6. PubMed ID: 9354430 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation. Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734 [TBL] [Abstract][Full Text] [Related]
3. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells. Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines. Liu TJ; Wang M; Breau RL; Henderson Y; El-Naggar AK; Steck KD; Sicard MW; Clayman GL Cancer Gene Ther; 1999; 6(2):163-71. PubMed ID: 10195883 [TBL] [Abstract][Full Text] [Related]
5. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck. Frank DK; Liu TJ; Frederick MJ; Clayman GL Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148 [TBL] [Abstract][Full Text] [Related]
6. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells. Elliott MJ; Dong YB; Yang H; McMasters KM Clin Cancer Res; 2001 Nov; 7(11):3590-7. PubMed ID: 11705881 [TBL] [Abstract][Full Text] [Related]
7. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells. Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668 [TBL] [Abstract][Full Text] [Related]
8. Functional interplay between p53 and E2F through co-activator p300. Lee CW; Sørensen TS; Shikama N; La Thangue NB Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736 [TBL] [Abstract][Full Text] [Related]
9. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin. Dong YB; Yang HL; McMasters KM Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937 [TBL] [Abstract][Full Text] [Related]
10. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Meng RD; Phillips P; El-Deiry WS Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003 [TBL] [Abstract][Full Text] [Related]
11. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431. Ahmad N; Gupta S; Mukhtar H Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343 [TBL] [Abstract][Full Text] [Related]
12. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol. Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161 [TBL] [Abstract][Full Text] [Related]
13. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389 [TBL] [Abstract][Full Text] [Related]
14. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Zhang SY; Liu SC; Johnson DG; Klein-Szanto AJ Cancer Res; 2000 Nov; 60(21):5972-6. PubMed ID: 11085515 [TBL] [Abstract][Full Text] [Related]
15. E2F-1-induced p53-independent apoptosis in transgenic mice. Holmberg C; Helin K; Sehested M; Karlström O Oncogene; 1998 Jul; 17(2):143-55. PubMed ID: 9674698 [TBL] [Abstract][Full Text] [Related]
16. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression. Nip J; Hiebert SW Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040 [TBL] [Abstract][Full Text] [Related]
17. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex. Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981 [TBL] [Abstract][Full Text] [Related]
18. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Santoni-Rugiu E; Jensen MR; Thorgeirsson SS Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068 [TBL] [Abstract][Full Text] [Related]
19. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Johnson DG; Schwarz JK; Cress WD; Nevins JR Nature; 1993 Sep; 365(6444):349-52. PubMed ID: 8377827 [TBL] [Abstract][Full Text] [Related]
20. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein. Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]